Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas | Zendy

Josep Muncunill | Zendy; Maria João Baptista | Zendy; Àgueda Hernández-Rodríguez | Zendy; Judith Dalmau | Zendy; Olga García | Zendy; Gustavo Tapia | Zendy; Miriam Moreno | Zendy; JuanManuel Sancho | Zendy; Javier MartínezPicado | Zendy; Evarist Feliú | Zendy; José Luís Mate | Zendy; JosepMaría Ribera | Zendy; JoséTomás Navarro | Zendy

Open Access

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas

Author(s) -

Josep Muncunill,

Maria João Baptista,

Àgueda Hernández-Rodríguez,

Judith Dalmau,

Olga García,

Gustavo Tapia,

Miriam Moreno,

JuanManuel Sancho,

Javier MartínezPicado,

Evarist Feliú,

José Luís Mate,

JosepMaría Ribera,

JoséTomás Navarro

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy542

Subject(s) - lymphoma , medicine , viral load , biomarker , virus , epstein–barr virus , immunology , biology , biochemistry

Epstein-Barr virus (EBV) has been implicated in lymphomagenesis and can be found infecting tumor cells and in plasma at lymphoma diagnosis, especially in human immunodeficiency virus (HIV)-infected patients. Our aim was to evaluate the usefulness of plasma EBV load as biomarker and prognostic factor in HIV-positive patients with lymphomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research